Fontes, Aparecida Maria; Davis, Brian M; Encell, Lance P et al. (2006) Differential competitive resistance to methylating versus chloroethylating agents among five O6-alkylguanine DNA alkyltransferases in human hematopoietic cells. Mol Cancer Ther 5:121-8
|
Zielske, Steven P; Lingas, Karen T; Li, Yan et al. (2004) Limited lentiviral transgene expression with increasing copy number in an MGMT selection model: lack of copy number selection by drug treatment. Mol Ther 9:923-31
|
Zielske, Steven P; Gerson, Stanton L (2003) SarCNU mediates selection of P140K methylguanine-DNA-methyltransferase transduced human CD34(+) cells in vitro. Blood Cells Mol Dis 31:48-50
|
Reese, Jane S; Liu, Lili; Gerson, Stanton L (2003) Repopulating defect of mismatch repair-deficient hematopoietic stem cells. Blood 102:1626-33
|
Bowman, Janice E; Reese, Jane S; Lingas, Karen T et al. (2003) Myeloablation is not required to select and maintain expression of the drug-resistance gene, mutant MGMT, in primary and secondary recipients. Mol Ther 8:42-50
|
Vollweiler, J L; Zielske, S P; Reese, J S et al. (2003) Hematopoietic stem cell gene therapy: progress toward therapeutic targets. Bone Marrow Transplant 32:1-7
|
Zielske, Steven P; Gerson, Stanton L (2003) Cytokines, including stem cell factor alone, enhance lentiviral transduction in nondividing human LTCIC and NOD/SCID repopulating cells. Mol Ther 7:325-33
|
Zielske, Steven P; Reese, Jane S; Lingas, Karen T et al. (2003) In vivo selection of MGMT(P140K) lentivirus-transduced human NOD/SCID repopulating cells without pretransplant irradiation conditioning. J Clin Invest 112:1561-70
|
Liu, Lili; Schwartz, Stuart; Davis, Brian M et al. (2002) Chemotherapy-induced O(6)-benzylguanine-resistant alkyltransferase mutations in mismatch-deficient colon cancer. Cancer Res 62:3070-6
|
Wadhwa, Punit D; Zielske, Steven P; Roth, Justin C et al. (2002) Cancer gene therapy: scientific basis. Annu Rev Med 53:437-52
|
Showing the most recent 10 out of 45 publications